SFS
PCRX icon

Sowell Financial Services’s Pacira BioSciences PCRX Stock Holding History

Sowell Financial Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,929
Closed -$122K – 2073
2021
Q1 		$122K Sell
1,929
-572
-23% -$40.9K ﹤0.01% 1278
2020
Q4 		$150K Sell
2,501
-2
-0.1% -$117 0.01% 977
2020
Q3 		$150K Buy
2,503
+205
+9% +$11.9K 0.01% 828
2020
Q2 		$121K Sell
2,298
-657
-22% -$27.5K 0.01% 910
2020
Q1 		$99K Buy
2,955
+2,944
+26,764% +$122K 0.01% 842
2019
Q4 		$0 Sell
11
-20
-65% -$849 ﹤0.01% 2622
2019
Q3 		$1K Buy
+31
New +$1.24K ﹤0.01% 2287

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return